Who is eligible to receive the COVID-19 vaccination during Phase 2 of Operation Warp Speed?
PharmScript will supply the vaccine to patients and staff in long-term care facilities.
PharmScript will supply the vaccine to patients and staff in long-term care facilities.
Through an Emergency Use Authorization (EUA), the Food and Drug Administration (FDA) has determined that the Pfizer COVID-19 vaccine meets the required safety and effectiveness standards. PharmScript will continue to follow the CDC’s Guidance for Immunization Services.
Every vaccine has distinct clinical profiles, therefore causing certain clinical considerations and uncertainties. For the COVID-19 vaccine, by understanding these considerations PharmScript is better able to plan and prepare for administration. Some of these considerations consist of: Vaccine efficacy, safety, age of vaccine recipient, duration of immunity, route of administration, history of anaphylactic reactions Dosing [...]
According to the Centers for Disease Control and Prevention (CDC), the COVID-19 vaccine will help our bodies develop immunity to the virus that causes COVID-19 without us having to get the illness. Different types of vaccines work in different ways to offer protection, but with all types of vaccines, the body is left with the [...]
This is specific to the vaccine manufacturer being used by your pharmacy—based on either a 21- or 28-day cycle.
If a resident is admitted after the cut-off time they’ll be assigned to the next vaccine clinic date. If there happen to be extra vaccine doses available at your clinic, please contact the pharmacy to be led through the proper documentation process.
Yes, we can, assuming they use the same manufacturer.